Oncology Letters · 2018 · 16 citations · 24 references
MedicineMolecular BiologyOncologyCarcinogenesisMolecular OncologyOncogenesCancer Cell SignalingCancer ProgressionCervical CancerMalignant NeoplasmsOncogene ActivationOncogenic Signaling PathwaysCancer Signaling PathwaysMalignant ProgressionOncogene RegulationOvarian Cancer PathogenesisRegulation By E3 Ubiquitin Ligases
Ubiquitin E3 Ligase MARCH7 is involved in T cell proliferation and neuronal development. In our previous study, we demonstrated MARCH7 promoted malignant behavior of ovarian cancer via the nuclear factor (NF)-κB and Wnt/β-catenin signaling pathway. However, the expression and function of MARCH7 in cervical cancer remains unknown. The present study aimed to unravel the expression and function of MARCH7 in cervical cancer to elucidate its potential role in the diagnosis and pathogenesis of cervical cancer. Results indicated that the expression of MARCH7 was abnormally high in cervical cancer tissues than normal cervical tissues. However, silencing the expression of MARCH7 in HeLa cells resulted in decreased cell proliferation and invasion. Mechanistic investigations revealed that MARCH7 interacted with VAV2. Silencing the expression of MARCH7 in HeLa cells inhibited the VAV2-RAC1-CDC42 signaling pathway. Overall, the results of the present study identified MARCH7 as a candidate oncogene in cervical cancer, and a potential target for cervical cancer therapy.
24
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Vav2 Is an Activator of Cdc42, Rac1, and RhoA
Karon Abe, Kent L. Rossman, Betty Liu et al. · Journal of Biological Chemistry · 2000 · 256 citations · Full text
Karl Ulrich Petry · Scandinavian Journal of Clinical and Laboratory Investigation · 2014 · 139 citations · Full text
Medicine, Gynecology, Oncology +17